One area of application of such a finding is in cancer chemotherapeutics designed to trigger cell death by activating the apoptosis regulators Bax and Bak, which elicit IL-1β secretion during the late stages of apoptosis, most likely through caspase-3/-7-mediated pannexin-1 cleavage [129]. Here, IL1B is linked to cancer.